AAAAAA

   
Results: 1-16 |
Results: 16
Primary systemic anaplastic large-cell lymphoma (CD30(+)): Advances in biology and current therapeutic approaches
Authors: Fiorani, C Vinci, G Sacchi, S Bonaccorsi, G Artusi, T
Citation: C. Fiorani et al., Primary systemic anaplastic large-cell lymphoma (CD30(+)): Advances in biology and current therapeutic approaches, CLIN LYMPHO, 2(1), 2001, pp. 29-37
Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
Authors: Sacchi, S Federico, M Dastoli, G Fiorani, C Vinci, G Clo, V Casolari, B
Citation: S. Sacchi et al., Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab, CR R ONC H, 37(1), 2001, pp. 13-25
Clinical activity and safety of combination immunotherapy with interferon-alpha 2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma
Authors: Sacchi, S Federico, M Vitolo, U Boccomini, C Vallisa, D Baldini, L Petrini, M Rupoli, S Di Raimondo, F Merli, F Liso, V Tabilio, A Saglio, G Vinci, G Brugiatelli, M Dastoli, G
Citation: S. Sacchi et al., Clinical activity and safety of combination immunotherapy with interferon-alpha 2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(9), 2001, pp. 951-958
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia
Authors: Fiorani, C Sacchi, S Bonacorsi, G Cosenza, M
Citation: C. Fiorani et al., Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia, HAEMATOLOG, 85(9), 2000, pp. 1006-1007
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L
Authors: Sacchi, S Vinci, G Gugliotta, L Rupoli, S Gargantini, L Martinelli, V Baravelli, S Lazzarino, M Finazzi, G
Citation: S. Sacchi et al., Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L, HAEMATOLOG, 85(5), 2000, pp. 492-495
The influence of further education on occupational mobility in Switzerland
Authors: Li, JH Konig, M Buchmann, M Sacchi, S
Citation: Jh. Li et al., The influence of further education on occupational mobility in Switzerland, EUR SOCIOL, 16(1), 2000, pp. 43-65
Persistent polyclonal B lymphocytosis: morphological, immunological, cytogenetic and molecular analysis of an Italian case
Authors: Tonelli, S Vanzanelli, P Sacchi, S Fiorani, C Castelli, I Temperani, P Bonacorsi, G
Citation: S. Tonelli et al., Persistent polyclonal B lymphocytosis: morphological, immunological, cytogenetic and molecular analysis of an Italian case, LEUK RES, 24(10), 2000, pp. 877-879
Ranking or rating? A critical discussion of Klein and Arzheimer's study
Authors: Sacchi, S
Citation: S. Sacchi, Ranking or rating? A critical discussion of Klein and Arzheimer's study, KOLNER Z SO, 52(3), 2000, pp. 541
Conflict in modern societies
Authors: Sacchi, S
Citation: S. Sacchi, Conflict in modern societies, KOLNER Z SO, 52(1), 2000, pp. 160-161
The freshwater cyanobacterium Planktothrix sp FP1: molecular identification and detection of paralytic shellfish poisoning toxins
Authors: Pomati, F Sacchi, S Rossetti, C Giovannardi, S Onodera, H Oshima, Y Neilan, BA
Citation: F. Pomati et al., The freshwater cyanobacterium Planktothrix sp FP1: molecular identification and detection of paralytic shellfish poisoning toxins, J PHYCOLOGY, 36(3), 2000, pp. 553-562
Toxic cyanobacterial blooms in Lake Varese (Italy): A multidisciplinary approach
Authors: Giovannardi, S Pollegioni, L Pomati, F Rossetti, C Sacchi, S Sessa, L Calamari, D
Citation: S. Giovannardi et al., Toxic cyanobacterial blooms in Lake Varese (Italy): A multidisciplinary approach, ENVIRON TOX, 14(1), 1999, pp. 127-134
The role of interferon-alpha in the treatment of myeloproliferative disorders
Authors: Fiorani, C Tonelli, S Casolari, B Sacchi, S
Citation: C. Fiorani et al., The role of interferon-alpha in the treatment of myeloproliferative disorders, CUR PHARM D, 5(12), 1999, pp. 987-1013
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
Authors: Sacchi, S Kantarjian, HM Freireich, EJ O'Brien, SO Cortes, J Rios, MB Kornblau, S Giles, FJ Koller, C Gajewski, J Talpaz, M
Citation: S. Sacchi et al., Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia, LEUK LYMPH, 35(5-6), 1999, pp. 483-489
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma
Authors: Longo, G Fiorani, C Sacchi, S Callea, V Lombardo, M Federico, M Stelitano, C Angrilli, F Vallisa, D Gobbi, PG Ilariucci, F Frassoldati, A Petrini, M Silingardi, V
Citation: G. Longo et al., Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma, HAEMATOLOG, 84(5), 1999, pp. 425-430
Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
Authors: Sacchi, S Kantarjian, HM O'Brien, S Cortes, J Rios, MB Giles, FJ Beran, M Koller, CA Keating, MJ Talpaz, M
Citation: S. Sacchi et al., Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients, CANCER, 86(12), 1999, pp. 2632-2641
Anionic binding site and 2,3-DPG effect in bovine hemoglobin (vol 37, pg 14024, 1998)
Authors: Marta, M Patamia, M Colella, A Sacchi, S Pomponi, M Kovacs, KM Lydersen, C Giardina, B
Citation: M. Marta et al., Anionic binding site and 2,3-DPG effect in bovine hemoglobin (vol 37, pg 14024, 1998), BIOCHEM, 38(2), 1999, pp. 854-854
Risultati: 1-16 |